临床的肌肉学和预后特征的临床的氨基病性皮肤肌炎
Marco Fornaro1, Francesco Girolamo2, Margherita Giannini3
1Unit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica (DiMePRe-J), University of Bari, Italy.
Clinical and experimental rheumatology
|March 15, 2024
概括
临床 Amyopathic Dermatomyositis (CADM) 患者具有独特的特征,包括早期发病和独特的自身抗体配置文件. 尽管正常的肌肉测试,活检显示肌肉炎症,但CADM没有影响生存率.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 皮肤肌肉炎 (DM) 是一种异常性炎症性肌肉病.
- 临床骨髓炎性皮肤肌炎 (CADM) 是一种亚型,其特点是皮肤表现没有显著的肌肉衰弱.
- 了解CADM独特的临床,组织学和预后特征对于患者管理至关重要.
研究的目的:
- 为了全面描述临床氨基病性皮肤肌炎 (CADM).
- 通过临床,组织学和预后参数,将CADM与经典的DM和低肌病性DM (HDM) 进行比较.
- 为了确定DM亚型中死亡率的预测因素.
主要方法:
- 对DM队列的回顾性分析,将患者分为DM,HDM和CADM.
- 记录了临床数据,自身抗体概况和实验室/仪器发现.
- 肌肉活检分析了组织学差异,并使用Cox分析评估了生存数据.
主要成果:
- 与经典的DM相比,CADM患者在发病和诊断时更年轻.
- 在CADM中,抗MDA5和抗TIF1-γ抗体,关节炎和间歇性肺病 (ILD) 的比率更高.
- 肌肉活检显示,各组 sarcolemma MHC-I 表达方式相似,五年生存率相似.
结论:
- 在临床上,CADM是不同的,早期发病,特定的自身抗体,并增加关节/肺部的参与.
- 尽管肌肉强度正常,实验室检测不显著,但肌肉活检可以在CADM中显示炎症 (MHC-I过度表达).
- 间歇性肺病和癌症是主要的死亡预测因素,而不是特定的DM亚型.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
823
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
823
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Disorders of the Skeletal Muscle
943
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
943


